Is Travere Therapeutics, Inc. (TVTX) a Buy, Sell, or Hold?
NASDAQ : TVTX
Travere Therapeutics, Inc. — Analyst Ratings
$57.36 USD
$0.68 (1.2%)
- Volume
- 1.23M
- Average Volume
- 2.1M
- Market Capitalization
- $5.33B
- P/E Ratio
- -117.06
- Dividend Yield
- 0.00%
- Price Target
- $65.00
- Year High
- $60.10
- Year Low
- $15.03
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $3.13
Analyst Consensus Summary
Consensus Rating
Strong Sell
18 Analysts
Rating Score
1/5
Recommendation Strength
Upside/Downside
-11.8%
vs Current Price
Price Target
$65.00
Average TargetPrice Target Range
Lowest Target
$49.00
17.1% UPSIDE
Average Target
$65.00
Median Estimate
Highest Target
$67.00
-14.4% DOWNSIDEAnalyst Breakdown
Overall Consensus: Buy | Total Analysts: 18
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 0 | 15 | 3 | 0 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Guggenheim | Vamil Divan | $65 | $59.4 | 2026-06-25 07:38 AM | 9.4% |
| H.C. Wainwright | Joseph Pantginis | $67 | $42.96 | 2026-06-02 11:38 AM | 56.0% |
| Guggenheim | Vamil Divan | $49 | $28.392 | 2026-01-14 06:48 AM | 72.6% |
| Jefferies | Maury Raycroft | $35 | $27.31 | 2025-09-10 10:48 AM | 28.2% |
| Evercore ISI | Liisa Bayko | $33 | $17.5 | 2024-10-31 04:21 PM | 88.6% |
| Wells Fargo | Mohit Bansal | $27 | $17.87 | 2024-10-21 01:38 AM | 51.1% |
| Evercore ISI | Liisa Bayko | $30 | $18.07 | 2024-10-10 05:24 AM | 66.0% |
| Bank of America Securities | Jason Zemansky | $20 | $15.21 | 2024-10-09 02:57 AM | 31.5% |